Editors' ChoiceCancer

A new hope for neuroblastoma treatment?

See allHide authors and affiliations

Science Translational Medicine  18 Dec 2019:
Vol. 11, Issue 523, eaaz9769
DOI: 10.1126/scitranslmed.aaz9769

Abstract

Combined ALK and PIM1 inhibition may treat high-risk neuroblastomas.

View Full Text

Stay Connected to Science Translational Medicine